| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/30/2009 | US20090191130 De novo synthesis of bacteriochlorins |
| 07/30/2009 | US20090191129 Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors |
| 07/30/2009 | US20090191127 Omentum and use thereof |
| 07/30/2009 | US20090191125 Diagnostic and Therapeutic Alkyl Piperidine/Piperazine Compounds and Process |
| 07/30/2009 | US20090188497 Medical product containing tiotropium |
| 07/30/2009 | US20090188496 Inhalable tiotropium and container therefor |
| 07/30/2009 | US20090188495 Pre-metered dry powder inhaler for moisture-sensitive medicaments |
| 07/30/2009 | US20090188491 Medicaments |
| 07/30/2009 | US20090188305 Reference standard for characterization of rosuvastatin |
| 07/30/2009 | DE4245089B4 Oral pharmaceutical compsn. for treating hyperlipoproteinaemia or atherosclerosis - comprises hydroxymethyl glutaryl coenzyme A reductase cholesterol inhibitor |
| 07/30/2009 | DE202008010830U1 Arzneimittel und Nahrungsergänzungsmittel mit einem Gehalt an stabilisiertem Ubichinol in einer Schutzverpackung Medicines and dietary supplements containing stabilized ubiquinol in protective packaging |
| 07/30/2009 | DE19549794B4 Microemulsion pre-concentrate of active agent with low solubility - with carrier medium comprising hydrophilic phase contg. di-methyl-isosorbide and/or alkanoic ester, lipophilic phase and surfactant |
| 07/30/2009 | DE102008006416A1 Clindamycin or its salt, or a clindamycin-containing composition useful for the intracervical or endocervical treatment or prevention of bacterial vaginosis caused by anaerobic and gram positive aerobic germs |
| 07/30/2009 | DE102008006394A1 Verwendung von Wirkstoffkomplexen aus Panthenol, Glycerin, Citrat und/oder Bisabolol gegen Pollenallergien Use of active complexes of panthenol, glycerin, citrate and / or bisabolol to pollen allergies |
| 07/30/2009 | DE102007057718A1 New heteroaryl-substituted piperidine compounds are protease-activated receptor antagonists useful for the treatment and/or prophylaxis of e.g. cardiovascular diseases, thromboembolic diseases, tumors, stroke, hypertension and asthma |
| 07/30/2009 | CA2749742A1 3-(sulfonyl)pyrazolo[1,5-a]pyrimidines - antagonists of serotonin 5-ht6 receptors, methods for their preparation and use |
| 07/30/2009 | CA2714269A1 Novel salt of tegaserod |
| 07/30/2009 | CA2713997A1 New 2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indole compounds and methods of use thereof |
| 07/30/2009 | CA2713373A1 Abuse resistant melt extruded formulation having reduced alcohol interaction |
| 07/30/2009 | CA2713131A1 Topically active steroids for use in interstitial pulmonary fibrosis |
| 07/30/2009 | CA2713128A1 Pharmaceutical dosage form |
| 07/30/2009 | CA2713111A1 4-pyridinone compounds and their use for cancer |
| 07/30/2009 | CA2713105A1 Methods of treating viral infections |
| 07/30/2009 | CA2713104A1 Protopanaxadiol-type ginsenoside compositions and uses thereof |
| 07/30/2009 | CA2712998A1 Beta-amino acid derivatives for treatment of diabetes |
| 07/30/2009 | CA2712959A1 Indolyl-pyridone derivatives having checkpoint kinase 1 inhibitory activity |
| 07/30/2009 | CA2712940A1 Heteroaryl-containing tripeptide hcv serine protease inhibitors |
| 07/30/2009 | CA2712910A1 Pharmaceutical composition for inhibiting amyloid-beta protein accumulation |
| 07/30/2009 | CA2712791A1 Fused pyridines active as inhibitors of c-met |
| 07/30/2009 | CA2712750A1 Aldh-2 inhibitors in the treatment of addiction |
| 07/30/2009 | CA2712748A1 13,13-dimethyl-des-c,d analogs of 1.alpha.,25-dihydroxy-19-nor-vitamin d3 compounds and topical composition dosage forms and methods of treating skin conditions thereof |
| 07/30/2009 | CA2712741A1 Hydrazines in glaucoma therapy |
| 07/30/2009 | CA2712731A1 Volatile anesthetic compositions comprising extractive solvents for regional anesthesia and/or pain relief |
| 07/30/2009 | CA2712685A1 Novel heterocyclic compounds |
| 07/30/2009 | CA2712619A1 Dihydropyridine calcium antagonist compounds, preparation methods and medical uses thereof |
| 07/30/2009 | CA2712612A1 4-(pyrrolo[2,3-c]pyridine-3-yl)pyrimidin-2-ylamine derivatives |
| 07/30/2009 | CA2712516A1 Volatile anesthetic compositions and methods of use |
| 07/30/2009 | CA2712500A1 Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 07/30/2009 | CA2712448A1 Lactylates for the prevention and treatment of infections caused by gram-positive bacteria in animals |
| 07/30/2009 | CA2712388A1 Salt forms of a 6-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene derivative, process for their manufacture and pharmaceutical compositions containing same |
| 07/30/2009 | CA2712347A1 Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them |
| 07/30/2009 | CA2712282A1 Delayed release pharmaceutical composition of duloxetine |
| 07/30/2009 | CA2712222A1 Derivatives of aminoalkanols, method of obtaining of aminoalkanols and their use |
| 07/30/2009 | CA2712087A1 Method of optimizing the treatment of proliferative diseases mediated by the tyrosine kinase receptor kit with imatinib |
| 07/30/2009 | CA2712078A1 Treatment and prevention of cardiac conditions using two or more isoforms of hepatocyte growth factor |
| 07/30/2009 | CA2711887A1 Dihydro-1h-pyrrolo [1,2-a] indol-1-yl carboxylic derivatives which act as s1p1 agonists |
| 07/30/2009 | CA2711873A1 New use for cannabinoids |
| 07/30/2009 | CA2711713A1 Substituted amino-benzimidazoles, medicaments comprising said compound, their use and their method of manufacture |
| 07/30/2009 | CA2711629A1 Thienopyridazine compounds, their preparations, pharmaceutical compositions and uses |
| 07/30/2009 | CA2711576A1 Tricyclic compounds as modulators of tnf-.alpha. synthesis and as pde4 inhibitors |
| 07/30/2009 | CA2711535A1 Bicyclo-substituted pyrazolon azo derivatives, preparation process and pharmaceutical use thereof |
| 07/30/2009 | CA2711487A1 Quinolizidinone m1 receptor positive allosteric modulators |
| 07/30/2009 | CA2711134A1 Angiotensin ii receptor antagonists |
| 07/30/2009 | CA2711059A1 Crystalline form of abacavir that is essentially free of solvent |
| 07/30/2009 | CA2710745A1 Composition comprenant un retinoide et du peroxyde de benzoyle disperse |
| 07/30/2009 | CA2710538A1 Crystalline form of a (3s)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use |
| 07/30/2009 | CA2710474A1 Compounds comprising a cyclobutoxy group |
| 07/30/2009 | CA2709806A1 Protein kinase inhibitors and use thereof |
| 07/30/2009 | CA2709050A1 Sulfonamides as orexin antagonists |
| 07/30/2009 | CA2708661A1 Methods and compositions for diagnosing complications of pregnancy |
| 07/30/2009 | CA2708175A1 Phthalazinone derivatives |
| 07/30/2009 | CA2705251A1 Method for the preparation of morphine compounds |
| 07/30/2009 | CA2704128A1 Novel composition for treating the side effects of anticancer treatments |
| 07/29/2009 | EP2083458A1 Organic mesomeric compounds as dotands |
| 07/29/2009 | EP2083368A1 Database and method for creating a database for classifying and treating physiologic brain imbalances using quantitative eeg |
| 07/29/2009 | EP2083272A1 Cancer cell identification marker and cancer cell proliferation inhibitor |
| 07/29/2009 | EP2083270A1 A method and kit for detecting the early onset of renal tubular cell injury |
| 07/29/2009 | EP2083089A1 Detection of mutations in a gene associated with resistance to viral infection, oas1 |
| 07/29/2009 | EP2083018A2 Compositions and methods relating to STOP-1 |
| 07/29/2009 | EP2083014A2 Inhibitors of interleukin-1ß converting enzyme |
| 07/29/2009 | EP2083012A1 1,5-dihydro-2h-pyrrol-2-one tricyclic derivatives having pharmacological activity and processes for their preparation |
| 07/29/2009 | EP2083011A1 Pyrroline derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof |
| 07/29/2009 | EP2083010A1 Polymorphic Forms of Moxifloxacin hydrochloride and processes for preparation thereof |
| 07/29/2009 | EP2083009A1 Substituted tetrahydroimidazopyridine compounds and their use in medicine |
| 07/29/2009 | EP2083008A1 Ergoline derivatives as selective radical scavengers for neurons |
| 07/29/2009 | EP2083007A1 Tiotropium salts, method for creating same and medicinal formulations containing same |
| 07/29/2009 | EP2083006A1 Oxadiazolones, processes for their preparation and their use as pharmaceuticals |
| 07/29/2009 | EP2083005A1 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors |
| 07/29/2009 | EP2082745A1 Method for cancer therapy with a parvovirus combined with chemotherapy |
| 07/29/2009 | EP2082743A2 Inhibitors of GSK-3 and crystal structures of GSK-3beta protein and protein complexes |
| 07/29/2009 | EP2082742A1 Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic |
| 07/29/2009 | EP2082741A1 Novel crystal form of irinotecan hydrochloride |
| 07/29/2009 | EP2082740A2 Use of imidazole derivatives as MDR modulators |
| 07/29/2009 | EP2082739A1 Lactylates for the prevention and treatment of infections caused by gram-positive bacteria in animals |
| 07/29/2009 | EP2082738A1 Use of beta-hydroxy-beta-methylbutyrate to treat asthma |
| 07/29/2009 | EP2082737A2 Methods of inducing terminal differentiation |
| 07/29/2009 | EP2082736A1 Pharmaceutical composition for local use |
| 07/29/2009 | EP2082735A1 Amorphous Aripiprazole and Process for the Preparation thereof |
| 07/29/2009 | EP2082732A1 Orodispersible tablets of prednisolone |
| 07/29/2009 | EP2082731A1 Use of a combination of hesperidin and a micro-organism to act on the barrier function of the skin |
| 07/29/2009 | EP2082724A1 Use of cationic surfactant as antimicrobial activity enhancer in deodorants and oral care |
| 07/29/2009 | EP2082723A1 Topical anti-microbial compositions |
| 07/29/2009 | EP2082041A2 Novel genes related to glutaminyl cyclase |
| 07/29/2009 | EP2082040A2 Use of transcription factor inhibitor in the manufacture of a medicament |
| 07/29/2009 | EP2081964A2 Alginate and alginate lyase compositions and methods of use |
| 07/29/2009 | EP2081951A1 Progesterone receptor antagonists |
| 07/29/2009 | EP2081947A2 Process for the preparation of an (rp)-8-substituted camps |
| 07/29/2009 | EP2081946A2 Adenosine derivatives for the treatment of pain |
| 07/29/2009 | EP2081944A1 Novel morphine derivatives |
| 07/29/2009 | EP2081939A1 Benzimidazole derivatives as selective acid pump inhibitors |